This update presents figures from the National Drug-Related Deaths Index (NDRDI) on deaths due to poisoning (overdose) by alcohol and/or other drugs, and deaths among people who use drugs which are not due to poisoning (non-poisonings) for the period 2008-2017.
Since 2004, the HRB has invested €37.9 million to support the development of leaders in research in both the academic and clinical environments through the Research Leader Awards in Population Health and Health Services Research (RLA in PHHSR) and the Clinician Scientist Awards (CSA). This evaluation was conducted by the HRB to determine whether these […]
This is the annually updated bulletin from the National Drug Treatment Reporting System (NDTRS) on cases of treated problem alcohol use in Ireland. It covers the period 2012 to 2018. In this seven-year period, 54,263 cases were treated for alcohol as a main problem drug.
This is the annually updated bulletin from the National Drug Treatment Reporting System (NDTRS) on cases of treated problem drug use (excluding alcohol) in Ireland. It covers the period 2012 to 2018. In this seven-year period, 65,216 cases were treated for drug use as a main problem.
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
This report presents the outcomes of a review of HRB’s investment in clinical research infrastructures in Ireland conducted in 2018. The aim of the review was to generate appropriate evidence on current strengths, synergies, gaps, duplications and needs in Ireland’s clinical research infrastructures, either those funded directly or peripherally by the HRB, in order to […]
Inadequate community supports and deficiencies in access to services outside of regular office hours have been linked to poor outcomes for patients with life-limiting illness. Policy-makers, researchers, providers, patients, and carers in Ireland have all identified out-of-hours care as a key deficit in current service provision. The Department of Health commissioned this review to inform […]
Contents include: Chairperson and Chief Executive’s report; Snapshot of HRB activities during 2018; Key deliverables in line with HRB strategy 2016 – 2020; and Appendices. The Corporate Governance and Financial Statements were published in a Part 2 on 14 January 2020 following approval of the financial statements by the Office of the Comptroller and Auditor […]
The scope of this rapid realist review was developed through a high-level review of relevant literature and early engagement of knowledge users in Ireland. The Health Research Board (HRB) proposed three research questions to guide the rapid realist review. Keeping in line with the realist approach, the research team carried out a process to refine […]
The aim of this review of vaccine injury redress programmes in 11 jurisdictions was to investigate the association between design features of the programmes and operating costs, timely access to compensation, number of applicants, and the volume and costs of awards. The databases MEDLINE, CINAHL, Scopus, Web of Science, Cochrane Library, HeinOnline, and LegalTrac were […]
The 2018 report provides data presented nationally as well as: * CHO * county * hospital type * individual psychiatric units/hospitals
In Europe, many people with intellectual disabilities continue to live in congregated settings. In 2012, Ireland formally introduced a resettlement policy with people moving to live in more personalised arrangements. This longitudinal country case-study aimed to monitor the implementation of this policy and the intra-country variations that arose using the records maintained in the National […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
This is the annually updated bulletin from the National Drug Treatment Reporting System (NDTRS) on cases of treated problem drug use (excluding alcohol) in Ireland. It covers the period 2011 to 2017. In this seven-year period, 63,303 cases were treated for drug use as a main problem.
This information review, undertaken on behalf of the Department of Health, informs the National Healthy Workplace Framework and implementation plan and will contribute to the business case for healthy workplace programmes. Five anglophone countries (Australia, Canada, New Zealand, Scotland and the USA) were included in the review. This information review found that in each of […]
This is the annually updated bulletin from the National Drug Treatment Reporting System (NDTRS) on cases of treated problem alcohol use in Ireland. It covers the period 2011 to 2017. In this seven-year period 55,675 cases were treated for alcohol as a main problem drug. The number of cases treated has fallen slightly in recent […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
This update presents figures from the National Drug-Related Deaths Index (NDRDI) on deaths due to poisoning (overdose) by alcohol and/or other drugs, and deaths among people who use drugs which are not due to poisoning (non-poisonings) for the period 2004-2016.
Many studies show that incarcerated populations have higher rates of problem drug use than the general population. The purpose of this paper is to analyse trends in addiction treatment demand in prisons in Ireland from 2009 to 2014 using available national surveillance data in order to identify any implications for practice and policy.
This study examines funding awards based on the type of research conducted and the disease area of interest. It uses the United Kingdom (UK) Health Research Classification System (HRCS). Seven national funding agencies that manage research programmes provided data for this analysis. These were, Enterprise Ireland (EI), the Environmental Protection Agency (EPA), the HRB, the […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
The purpose of this review is to systematically evaluate the evidence on quality of life outcomes and costs associated with a move from a congregated setting to a community living arrangement for people with intellectual disability. The right to live independently in a place of one’s own choosing is a core value of the United […]
This HRB evidence review identifies 13 integrated interventions between the hospital and the community that were tested to see if they reduce pressure on acute hospitals among adults. In this review, a reduction in pressure on acute hospitals was measured by a reduction in adult: admissions to hospital; readmissions for the same condition; length of […]
Contents include Interim Chief Executive’s report; Snapshot of HRB activities during 2017; Key deliverables in line with HRB strategy 2016 – 2020; and Appendices. Part two, contains the full audited accounts, and was published on 20 May 2019 following approval of same by the Office of the Comptroller and Auditor General, and subsequent translation into […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
